These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16554888)

  • 1. [Vitamins E to premature infants].
    Huse J
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):933. PubMed ID: 16554888
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vitamin E mixture for children--treatment with a blindfold?].
    Westergren T; Kalikstad B
    Tidsskr Nor Laegeforen; 2006 Mar; 126(7):902-4. PubMed ID: 16554880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving and enforcing compounding pharmacy practices to protect patients.
    Pegues DA
    Clin Infect Dis; 2006 Oct; 43(7):838-40. PubMed ID: 16941363
    [No Abstract]   [Full Text] [Related]  

  • 4. [The new pharmacy law--for the best of the state or the patients?].
    Vigen T
    Tidsskr Nor Laegeforen; 1999 Oct; 119(26):3883. PubMed ID: 10592742
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of standardized total parenteral nutrient solutions for premature neonates.
    Hartwig SC; Gardner DK
    Am J Hosp Pharm; 1989 May; 46(5):993-5. PubMed ID: 2499193
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drugs supply disruption].
    Arzalier-Daret S
    Ann Fr Anesth Reanim; 2013 Mar; 32(3):127-9. PubMed ID: 23414926
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of the Food and Drug Administration's current good manufacturing practices regulations to pharmacy practice: a legal view.
    Fink JL
    Contemp Pharm Pract; 1979; 2(4):202-5. PubMed ID: 10244540
    [No Abstract]   [Full Text] [Related]  

  • 8. High serum vitamin E levels in premature infants receiving MVI-Pediatric.
    Kerner JA; Poole RL; Sunshine P; Stevenson DK
    J Pediatr Perinat Nutr; 1987; 1(1):75-82. PubMed ID: 3694523
    [No Abstract]   [Full Text] [Related]  

  • 9. [Is it justifiable to administrate vitamin A, E and D for 6 months in the premature infants?].
    Salle BL; Delvin E; Claris O; Hascoet JM; Levy E
    Arch Pediatr; 2007 Dec; 14(12):1408-12. PubMed ID: 17964126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Court files order in pharmacies' case against FDA.
    J Am Vet Med Assoc; 2006 Oct; 229(8):1228. PubMed ID: 17066572
    [No Abstract]   [Full Text] [Related]  

  • 11. [Restriction in prescription of methadone. Change in the regulation of February 19, 1965, about prescribing and dispensing drugs by pharmacies].
    Nor Tannlaegeforen Tid; 1976 Jul; 86(7):320. PubMed ID: 1065858
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs.
    Patsner B
    Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473
    [No Abstract]   [Full Text] [Related]  

  • 13. [The change of the new veterinary drug legislation for delivery of veterinary drugs].
    Schutte F
    Tijdschr Diergeneeskd; 2006 Jan; 131(2):54-5. PubMed ID: 16454094
    [No Abstract]   [Full Text] [Related]  

  • 14. DEA addresses queries about Internet pharmacies.
    J Am Vet Med Assoc; 2001 Aug; 219(4):423-4. PubMed ID: 11518160
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of a state society in pharmacist-prescribing legislation.
    Breland BD; Wetherbee H
    Am J Hosp Pharm; 1984 Sep; 41(9):1758,1760. PubMed ID: 6496508
    [No Abstract]   [Full Text] [Related]  

  • 16. [Errors in the wording and dispatching of section 5 prescriptions].
    Laursen E; Jensen LE
    Ugeskr Laeger; 1989 May; 151(18):1133-6. PubMed ID: 2734887
    [No Abstract]   [Full Text] [Related]  

  • 17. Compounding of vitamin A, D3, E and K3 supplements for cystic fibrosis patients: formulation and stability study.
    Huyghebaert N; De Beer J; Vervaet C; Remon JP
    J Clin Pharm Ther; 2007 Oct; 32(5):489-96. PubMed ID: 17875116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entry of new pharmacies in the deregulated Norwegian pharmaceuticals market--consequences for costs and availability.
    Rudholm N
    Health Policy; 2008 Aug; 87(2):258-63. PubMed ID: 18164509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulk compounding.
    Wilson WD
    Can J Hosp Pharm; 1988 Feb; 41(1):39. PubMed ID: 10286610
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacy compounding: customizing prescription drugs.
    Nordenberg T
    FDA Consum; 2000; 34(4):11-2. PubMed ID: 11924628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.